Metric Finance
LearnFAQ
LearnFAQ

Learn / PBLS

NASDAQ: PBLS

Parabilis Medicines (PBLS) stock, explained like you're 5

Parabilis Medicines trades on the Nasdaq under the ticker PBLS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.

Ticker
PBLS
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 3.4 billion dollars

Is Parabilis Medicines a small, medium or large cap company?

No. Parabilis Medicines is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Parabilis Medicines makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves PBLS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Parabilis Medicines, Inc. (PBLS) stock price, news, quote and history (Yahoo Finance UK)
  • Top Parabilis Medicines (PBLS) Competitors 2026 (MarketBeat)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • Parabilis Medicines (Nasdaq:PBLS) Stock Analysis (Simply Wall Street)
  • $PBLS stock is down 13% today. Here's what we see in our data. (Quiver Quantitative)

Follow PBLS in your daily brief

Each trading day at 5 PM ET we post what happened to Parabilis Medicines and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow PBLS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Parabilis Medicines stock

What does Parabilis Medicines do?

Parabilis Medicines trades on the Nasdaq under the ticker PBLS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.4 billion dollars.

What is the ticker symbol for Parabilis Medicines?

Parabilis Medicines trades under the ticker PBLS on the Nasdaq.

What is Parabilis Medicines's market cap?

Parabilis Medicines is a mid cap stock with a market cap of about 3.4 billion dollars.

How does Parabilis Medicines make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves PBLS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow PBLS stock every day?

Add PBLS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow PBLS daily

A free brief on Parabilis Medicines and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare PBLS: PBLS vs NVS, PBLS vs AZN, PBLS vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed